Navigation Links
New type of stent could help some brain aneurysm patients
Date:7/9/2014

CHICAGO After Susan Wakulich was told she had an aneurysm, she figured an invasive brain surgery and lengthy recovery lay ahead of her.

"I was devastated," said Wakulich, who is 56 years old and lives in Chicago's western suburbs. "I knew this was a serious diagnosis. Then I met Dr. Bernard Bendok who told me about a new trial that involved a less invasive procedure. It was something I didn't even know was an option."

Northwestern Medicine is participating in a multi-center U.S. clinical trial to evaluate the safety and effectiveness of the Microvention Inc. FRED flow diversion system (Flow Re-Direction EndoluminalDevice) for the treatment of wide-necked intracranial aneurysms. Wakulich was the first individual at Northwestern Memorial Hospital and one of the first in the Chicago area - to enroll in a this trial that involves inserting a small, metallic mesh tube via a micro-catheter into the blood vessel across the entrance to the aneurysm. The device contains the flow of blood within the tube to keep it away from the aneurysm. This causes the aneurysm to clot and minimizes the chance of rupture.

Bernard R. Bendok, MD, a neurological surgeon at Northwestern Memorial, performed Wakulich's surgery on March 12. She was released from the hospital three days later and continues to recover.

"Historically, large aneurysms, such as the one like Susan's, are particularly difficult to treat," said Bendok, who is also a professor of neurological surgery, radiology and otolaryngology at Northwestern University Feinberg School of Medicine. "This new device system may offer additional benefits over first generation flow diversion devices because it can be partially deployed, retrieved and accurately repositioned or redeployed to ensure the most precise placement."

An estimated six million people in the United States have an unruptured brain aneurysm. An aneurysm is a weak area in the wall of a blood vessel that causes the blood vessel to bulge or balloon out. When an aneurysm occurs in a blood vessel of the brain, it is called a cerebral aneurysm. According to the National Institutes of Health, people with a small, unruptured aneurysm may have few if any symptoms, while a growing aneurysm may result in localized headaches, eye pain, vision problems or loss of feeling in the face. In the event of a rupture, symptoms are sudden and severe and can include headache, nausea and unconsciousness.

Traditionally, there are two main treatment options for patients who need to have their aneurysm surgically treated -- open surgical clipping or endovascular therapy, or coiling. Surgical clipping involves preventing the blood flow from entering the aneurysm. The second option packs coils into the aneurysm preventing blood flow from entering the aneurysm.

Although aneurysms can occur at any age, they are most prevalent in adults ages 35 to 60 and more common in women than in men. Dr. Bendok recommends that people with a strong family history of aneurysms be screened. Identifying and treating an aneurysm before it ruptures can make the difference between life and death. A ruptured aneurysm is fatal in approximately 40 percent of cases.

"The results of this national trial could change the way large aneurysms are treated in a way that is a huge benefit to the patient," Bendok said. "Not only is this safer, it's less invasive, which drastically cuts recovery time. We are thrilled to offer participation in this study to our patients."


'/>"/>

Contact: Sheila Galloro
sgalloro@nmh.org
312-926-0735
Northwestern Memorial Hospital
Source:Eurekalert

Related medicine news :

1. Coating stents with vitamin C could reduce clotting risks
2. Low IQ students learn to read at 1st-grade level after persistent, intensive instruction
3. Study finds outcome data in clinical trials reported inadequately, inconsistently
4. Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines
5. Drug-eluting stents demonstrate better outcomes after 1 year than bare metal stents
6. Real-world heart procedure results consistent with scientific research
7. Biolimus still comparable to everolimus in year 2 of stent match-up
8. Anti-clotting agent helps reduce the incidence and impact of stent thrombosis during PCI
9. Asthma: DMP is largely consistent with guidelines
10. Research and Development Forecast of China's Coronary Stent Industry, 2013-2017
11. New report illustrates persistent global burden of anemia among high-risk populations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... certification process to promote standards of excellence for the field of eating disorders, ... March 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ...
(Date:10/13/2017)... ... October 13, 2017 , ... Southern ... and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice Frueh, ... cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU School ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes ... a mock evacuation of the facility as part of a disaster drill on October ... Hose EMS and Shelton City Emergency Manager, as well as the Connecticut Long ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids this ... by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited about ... ages; it is a non-competitive, non-timed event, which is all about having fun and ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
(Date:9/18/2017)... Mich. , Sept. 18, 2017  PMD Healthcare ... Specialty Pharmacy of Kalamazoo, Mich. , ... hub service that expedites and streamlines patient and provider ... PD 2.0, and wellness management services.  ... device used to measure lung function for a variety ...
Breaking Medicine Technology: